Thrombophilia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Thrombophilia}} | {{Thrombophilia}} | ||
{{CMG}} {{asiri}} | {{CMG}} {{AE}} {{asiri}} | ||
==Overview== | ==Overview== | ||
*The [[Thrombophilia_medical_therapy|treatment]] for thrombophilia depends on the underlying hypercoagulable state and the clinical presentation. | *The [[Thrombophilia_medical_therapy|treatment]] for thrombophilia depends on the underlying hypercoagulable state and the clinical presentation. | ||
Revision as of 05:10, 16 July 2016
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia medical therapy On the Web |
|
American Roentgen Ray Society Images of Thrombophilia medical therapy |
|
Risk calculators and risk factors for Thrombophilia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]
Overview
- The treatment for thrombophilia depends on the underlying hypercoagulable state and the clinical presentation.
- Treatment should be tailored to the individual patient.
- The risks and benefits, required monitoring, and costs associated with each form of anticoagulation should be discussed with the patient prior to initiation of therapy.
- The mainstay of therapy for thrombophilia is anticoagulation with either warfarin, low molecular weight heparin, direct Xa inhibitors, or direct thrombin inhibitors.
- Response to anticoagulation can be monitored clinically, or with repeat ultrasongraphy for deep vein thrombosis or measuring D-dimer levels after treatment.
Medical Therapy
The treatment algorithms for various thrombophilias are presented below:
- Prophylactic anticoagulation should be used in the following scenarios:
- Post surgery
- Pregnancy and Postpartum